Bausch Health Companies Inc. discovers and distributes pharmaceutical. The Company develops drugs for unmet medical needs in central nervous system disorders, eye health, and gastrointestinal diseases, as well as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetic devices. Bausch Health Companies serves customers worldwide.

Current Report (Form 8-K | Period ending 2024-11-01)

Current Report (Form 8-K | Period ending 2024-10-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bausch Health Companies (BHC US)

Current Report (Form 8-K | Period ending 2024-11-01)

Current Report (Form 8-K | Period ending 2024-10-30)

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Current Report (Form 8-K | Period ending 2024-08-01)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)